Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a prospective multicenter randomized controlled study.

Prone positioning (PP) acute respiratory distress syndrome (ARDS) adult extracorporeal membrane oxygenation (ECMO)

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
29 Feb 2024
Historique:
received: 27 11 2023
accepted: 03 01 2024
medline: 20 3 2024
pubmed: 20 3 2024
entrez: 20 3 2024
Statut: ppublish

Résumé

Current data supporting the use of prone positioning (PP) during venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with acute respiratory distress syndrome (ARDS) are limited. This prospective randomized controlled study aimed to determine whether PP implemented within 24 hours of ECMO can improve survival in these patients. From June 2021 to July 2023, 97 adult patients receiving VV-ECMO for ARDS in three centers were enrolled and 1:1 randomized into PP (n=49) and control groups (n=48). Patients in the PP group receiving prone positioning, while the control group were maintained in the supine position. The primary outcome was 30-day survival, and secondary outcomes included in-hospital survival and other clinical outcomes. All 97 patients were included for analysis. Patient characteristics did not significantly differ between the two groups. The median duration of PP was 81 hours, and the median number of PP sessions was 5 times. PP improved oxygenation and ventilator parameters. The incidence of complications during PP was low, with pressure sores being the most frequent (10.2%). The 30-day survival was significantly higher in the PP group (67.3% When initiated within 24 hours of ECMO, PP can improve 30-day survival in patients with ARDS receiving VV-ECMO. In addition, it may improve the successful ECMO weaning rate and reduce the duration of ECMO support. However, considering the limitations, more strictly designed, large sample prospective randomized controlled trials are proposed. Chinese Clinical Trial Registry ChiCTR2300075326.

Sections du résumé

Background UNASSIGNED
Current data supporting the use of prone positioning (PP) during venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with acute respiratory distress syndrome (ARDS) are limited. This prospective randomized controlled study aimed to determine whether PP implemented within 24 hours of ECMO can improve survival in these patients.
Methods UNASSIGNED
From June 2021 to July 2023, 97 adult patients receiving VV-ECMO for ARDS in three centers were enrolled and 1:1 randomized into PP (n=49) and control groups (n=48). Patients in the PP group receiving prone positioning, while the control group were maintained in the supine position. The primary outcome was 30-day survival, and secondary outcomes included in-hospital survival and other clinical outcomes.
Results UNASSIGNED
All 97 patients were included for analysis. Patient characteristics did not significantly differ between the two groups. The median duration of PP was 81 hours, and the median number of PP sessions was 5 times. PP improved oxygenation and ventilator parameters. The incidence of complications during PP was low, with pressure sores being the most frequent (10.2%). The 30-day survival was significantly higher in the PP group (67.3%
Conclusions UNASSIGNED
When initiated within 24 hours of ECMO, PP can improve 30-day survival in patients with ARDS receiving VV-ECMO. In addition, it may improve the successful ECMO weaning rate and reduce the duration of ECMO support. However, considering the limitations, more strictly designed, large sample prospective randomized controlled trials are proposed.
Trial Registration UNASSIGNED
Chinese Clinical Trial Registry ChiCTR2300075326.

Identifiants

pubmed: 38505030
doi: 10.21037/jtd-23-1808
pii: jtd-16-02-1368
pmc: PMC10944719
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1368-1377

Informations de copyright

2024 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1808/coif). The authors have no conflicts of interest to declare.

Auteurs

Hongjie Tong (H)

Department of Intensive Care Medicine, Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua, China.

Feiyan Pan (F)

Department of Intensive Care Medicine, Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua, China.

Xiaoling Zhang (X)

Department of Intensive Care Medicine, Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua, China.

Shengwei Jia (S)

Department of Intensive Care Unit, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China.

Rishik Vashisht (R)

Sentara Pulmonary Critical Care and Sleep Specialists, Sentara Norfolk General Hospital, Norfolk, Virginia, USA.

Kun Chen (K)

Department of Intensive Care Medicine, Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua, China.

Qianqian Wang (Q)

Department of Intensive Care Unit, The First Hospital of Jiaxing, Jiaxing, China.

Classifications MeSH